Allogene Therapeutics (ALLO) Technical (Analysis) Reports Allogene Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Allogene Therapeutics (ALLO)
Technical Analysis Report for USA stock ALLO Allogene Therapeutics. Dated: 30 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock ALLO Allogene Therapeutics then click here. or read Experts views on Allogene Therapeutics or Forecast & share price targets of Allogene Therapeutics
Allogene Therapeutics Opened at 1.86 and Closed at: 1.97, which is 8.12% of previous session's close. It moved within a range of 1.86 and 2.00
The session was a Bullish session with an average volume of 10523100, which is -10.68% of previous session's volumes.
Support for tomorrow is 1.92 and resistance for tomorrow is 2.06
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 1.89, 1.8 resistance for tomorrow's hourly charts is 2.03, 2.08
10 Day SMA for Allogene Therapeutics (ALLO) is 1.8 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Allogene Therapeutics (ALLO) is 1.89 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Allogene Therapeutics (ALLO) is 1.97 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 2.16 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Allogene Therapeutics is 1.86 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Allogene Therapeutics is at 1.89 and 200 DMA is at 1.86, while 50 DMA and 100 DMA are at 1.97 and 2.16 respectively
Allogene Therapeutics (ALLO) moving average of 20 SMA is at 1.89 and 20 EMA is at 1.87
| Date | Closing Price | 20 SMA | 20 EMA |
| 30 Thu Jul | 1.97 | 1.89 | 1.87 |
| 29 Wed Jul | 1.81 | 1.89 | 1.86 |
| 28 Tue Jul | 1.66 | 1.91 | 1.86 |
| 27 Mon Jul | 1.75 | 1.93 | 1.88 |
| 24 Fri Jul | 1.75 | 1.95 | 1.89 |
| 24 Fri Jul | 1.75 | 1.97 | 1.9 |
Allogene Therapeutics (ALLO) moving average of 50 SMA is at 1.97 and 50 EMA is at 1.95
| Date | Closing Price | 50 SMA | 50 EMA |
| 30 Thu Jul | 1.97 | 1.97 | 1.95 |
| 29 Wed Jul | 1.81 | 1.97 | 1.95 |
| 28 Tue Jul | 1.66 | 1.97 | 1.96 |
| 27 Mon Jul | 1.75 | 1.98 | 1.97 |
| 24 Fri Jul | 1.75 | 1.99 | 1.98 |
| 24 Fri Jul | 1.75 | 2 | 1.99 |
Allogene Therapeutics (ALLO) moving average of 100 SMA is at 2.16 and 100 EMA is at 1.99
| Date | Closing Price | 100 SMA | 100 EMA |
| 30 Thu Jul | 1.97 | 2.16 | 1.99 |
| 29 Wed Jul | 1.81 | 2.16 | 1.99 |
| 28 Tue Jul | 1.66 | 2.17 | 1.99 |
| 27 Mon Jul | 1.75 | 2.18 | 2 |
| 24 Fri Jul | 1.75 | 2.18 | 2.01 |
| 24 Fri Jul | 1.75 | 2.19 | 2.02 |
Allogene Therapeutics (ALLO) moving average of 200 SMA is at 1.86 and 200 EMA is at 1.86
| Date | Closing Price | 200 SMA | 200 EMA |
| 30 Thu Jul | 1.97 | 1.86 | 1.86 |
| 29 Wed Jul | 1.81 | 1.86 | 1.86 |
| 28 Tue Jul | 1.66 | 1.85 | 1.86 |
| 27 Mon Jul | 1.75 | 1.85 | 1.86 |
| 24 Fri Jul | 1.75 | 1.85 | 1.86 |
| 24 Fri Jul | 1.75 | 1.85 | 1.86 |
Teva Pharmaceutical has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Teva Pharmaceutical, about 6.53% more returns!
Haemonetics Corporation has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Haemonetics Corporation, about 19.25% more returns!
Glaxosmithkline Plc has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Glaxosmithkline Plc, about 4.27% more returns!
Charles River has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Charles River, about 7.57% more returns!
Allogene Therapeutics has performed better than Twist Bioscience in short term. Holding Allogene Therapeutics could be a better choice for now!
Allogene Therapeutics has performed better than Ovid Therapeutics in short term. Holding Allogene Therapeutics could be a better choice for now!
Omeros Corporation has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Omeros Corporation, about 21.57% more returns!
Immuron has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Immuron, about 5.3% more returns!
Galmed Pharmaceuticals has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Galmed Pharmaceuticals, about 13.33% more returns!
Allogene Therapeutics has performed better than Fennec Pharmaceuticals in short term. Holding Allogene Therapeutics could be a better choice for now!
Eyegate Pharmaceuticals has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Eyegate Pharmaceuticals, about 4.51% more returns!
Citius Pharmaceuticals has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Citius Pharmaceuticals, about 9.47% more returns!
Allogene Therapeutics has performed better than Cellectis S in short term. Holding Allogene Therapeutics could be a better choice for now!
Allogene Therapeutics has performed better than Biolinerx in short term. Holding Allogene Therapeutics could be a better choice for now!
Aytu Bioscience has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Aytu Bioscience, about 4.36% more returns!
Axsome Therapeutics has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Axsome Therapeutics, about 2.91% more returns!
Allogene Therapeutics has performed better than Axogen Inc in short term. Holding Allogene Therapeutics could be a better choice for now!
Adial Pharmaceuticals has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Adial Pharmaceuticals, about 19.64% more returns!
Allogene Therapeutics Technical analysis of indicators
Price action analysis of Allogene Therapeutics (ALLO) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Allogene Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Allogene Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Allogene Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Allogene Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Allogene Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.81 and Allogene Therapeutics ALLO stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Allogene Therapeutics ALLO stock. Volume based technical analysis of Allogene Therapeutics ALLO stock is negative.
Allogene Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock ALLO Allogene Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ALLO Experts View which covers a lot of information including buying and selling signals
ALLO future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Allogene Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Allogene Therapeutics (ALLO) Technical (Analysis) Reports Allogene Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


